Skip to Content

P-4081

Main Content

Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation | 2014

Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.

Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC

PubMed
PMID: 24769014

Abstract
Related Articles

CIBMTR Study #: 07-REV